By SSCP, TP53 mutation was detected in 47.6% of patients with nasal NK/T-cell lymphoma, which gave an insight into its role in the lymphomagenesis of nasal NK/T-cell lymphoma [628]. This evidence concerns the gene TP53 and extranodal nasal NK/T cell lymphoma.